Melanoma News

Dr Moschos on Treatment Strategies With Adoptive T-Cell Therapy in Melanoma

Stergios J. Moschos, MD, an associate professor of medicine in the Department of Medicine in the Division of Oncology at the University of North Carolina (UNC) Chapel Hill School of Medicine, UNC Health, emphasized the importance of appropriately administering bridging therapy to patients who are slated to receive the adoptive T-cell therapy lifileucel (Amtagvi).

Read More
MRV News
Melanoma News
Archive
Menu